These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2352165)

  • 1. Sensitive trace-first liquid chromatographic determination of 4-aminopyridine in 3,4-diaminopyridine.
    Perry JA; Chang M
    J Pharm Sci; 1990 May; 79(5):437-9. PubMed ID: 2352165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of A 3,4-diaminopyridine in plasma by liquid chromatography with electrochemical detection using solid-phase extraction.
    Goulay-Dufaÿ S; Do B; Le Hoang MD; Raust JA; Graffard H; Guyon F; Pradeau D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):261-6. PubMed ID: 15135099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats.
    Lemeignan M; Millart H; Lamiable D; Molgo J; Lechat P
    Brain Res; 1984 Jun; 304(1):166-9. PubMed ID: 6744035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of 3,4-diaminopyridine in human plasma.
    Lamiable D; Millart H; Lemeignan M; Vistelle R
    J Chromatogr; 1984 Jul; 309(1):222-4. PubMed ID: 6480771
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of 4-aminopyridine and 3,4-diaminopyridine in rat cerebrospinal fluid and serum.
    Lamiable D; Millart H
    J Chromatogr; 1983 Jan; 272(1):221-5. PubMed ID: 6841545
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrasound driven synthesis of reversed-phase stationary phases for liquid chromatography using 4-dimethyl-aminopyridine as acid-acceptor.
    Sentell KB; Barnes KW; Dorsey JG
    J Chromatogr; 1988 Nov; 455():95-104. PubMed ID: 3235626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 3,4-diaminopyridine in human plasma by high-performance liquid chromatography.
    Kamali F; Nicholson E
    J Pharm Biomed Anal; 1995 May; 13(6):791-4. PubMed ID: 7669834
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
    Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
    J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 4-aminopyridine in serum by solid-phase extraction and high-performance liquid chromatography.
    van der Horst A; de Goede PN; van Diemen HA; Polman CH; Martens HJ
    J Chromatogr; 1992 Feb; 574(1):166-9. PubMed ID: 1629282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment.
    Quartel A; Turbeville S; Lounsbury D
    Curr Med Res Opin; 2010 Jun; 26(6):1363-75. PubMed ID: 20377318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric dimethylaminopyridinium reagents for derivatization of weak nucleophiles in high-performance liquid chromatography-ultraviolet/fluorescence detection.
    Gao CX; Krull IS
    J Chromatogr; 1990 Aug; 515():337-56. PubMed ID: 2283367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability studies of ionised and non-ionised 3,4-diaminopyridine: hypothesis of degradation pathways and chemical structure of degradation products.
    Raust JA; Goulay-Dufaÿ S; Le Hoang MD; Pradeau D; Guyon F; Do B
    J Pharm Biomed Anal; 2007 Jan; 43(1):83-8. PubMed ID: 16844337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of experimental autoimmune myasthenia gravis in rabbits with 4-aminopyridine and 3,4-diaminopyridine].
    Li L; Zhang YP
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):358-62. PubMed ID: 7801782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anharmonic vibrational analysis of 3,4-diaminopyridine and 3-aminopyridine by density functional theory calculations.
    Karpagam J; Sundaraganesan N; Kalaichelvan S; Sebastian S
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Sep; 76(5):502-12. PubMed ID: 20483656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 3,4-diaminopyridine in human serum by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Leslie J; Bever CT
    J Chromatogr; 1989 Nov; 496(1):214-22. PubMed ID: 2556419
    [No Abstract]   [Full Text] [Related]  

  • 17. [3,4-Diaminopyridine and 4-aminopyridine evoked neurotransmitter release].
    Huang HY; Dai SP
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):28-32. PubMed ID: 1950580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids.
    Székely G; Henriques B; Gil M; Ramos A; Alvarez C
    J Pharm Biomed Anal; 2012 Nov; 70():251-8. PubMed ID: 22841555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic determination of 2,4-diaminopyridine in plasma and urine.
    Biessels PT; Agoston S; Horn AS
    J Chromatogr; 1987 Oct; 421(2):392-5. PubMed ID: 3429592
    [No Abstract]   [Full Text] [Related]  

  • 20. Enantiomeric purity determination of (L)-amino acids with pre-column derivatization and chiral stationary phase: development and validation of the method.
    Cui Y; Jiang Z; Sun J; Yu J; Li M; Li M; Liu M; Guo X
    Food Chem; 2014 Sep; 158():401-7. PubMed ID: 24731361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.